X. Han, Y. Wu, Y. Zhuang, and J. Zhang, “Dexmedetomidine reduces dextran sulfate sodium (DSS)-induced NCM460 cell inflammation and barrier damage by inhibiting RhoA/ROCK signaling pathway”, Allergol Immunopathol, vol. 50, no. 3, pp. 85–92, May 2022, doi: 10.15586/aei.v50i3.569.